Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease

Antioxidants and Redox Signaling

Volumn 2, Issue 3, 2000, Pages 551-573

  Perl, A ^a   Banki, K ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

GENETIC REGULATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; MEMBRANE POTENTIAL; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OPPORTUNISTIC INFECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033752413     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860050192323     Document Type: Review

References (220)

1. Role of redox potential and reactive oxygen species in stress signaling
2. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+)T- or monocytic cel lines
3. Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: A double-blind placebo-controlled trial
4. Fas transduces activation signals in normal human T lymphocytes
5. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection
6. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects
7. Uncoupling of incorporation of ascorbic acid and apoptosis induction
8. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection
9. Sodium benzylideneascorbate induces apoptosis in HIV-replicating U1 cells
10. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection
11. HIV-1 vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB
12. Oxidants from phagocytes: Agents of defense and destruction
13. Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
14. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression
15. Molecular ordering in HIV-induced apoptosis: Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase
16. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling
17. D-ribose and deoxy D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells
18. A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus
19. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53
20. Phosphorylation of IkB-α inhibits its cleavage by caspase CPP32 in vitro
21. 2 accumulation by a mechanism which differs from DNA damage checkpoint control
22. Cell surface trafficking of Fas: A rapid mechanism of p53-induced apoptosis
23. Superoxide dependence of the toxicity of short chain sugars
24. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFR1-induced apoptosis
25. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells
26. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling
27. T lymphocytes from AIDS patients are unable to synthesize ribonucleotides de novo in response to mitogenic stimulation
28. Upregulation of Fas ligand expression by human immunodefiociency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
29. Systemic glutathione deficiency in symptom-free HIV seropositive individuals
30. The human immunodeficiency virus type i Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure
31. Oxidative stress as a mediator or apoptosis
32. Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy
33. Does vitamin C act as a pro-oxidant under physiological conditions?
34. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx
35. Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor
36. 1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells
37. Control of programmed cell death by the baculovirus genes p35 and iap
38. The Th1-Th2 hypothesis of HIV infection: New insights
39. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression
40. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites
41. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS
42. The HIV wasting syndrome
43. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome
44. Glutathione depletion in HIV-infected patients: Role of cysteine deficiency and effect of oral N-acetylcysteine
45. The enzymatic antioxidant system in blood an glutathione status in human immunodeficiency virus (HIV)-infected patients: Effects of supplementation with selenium or β-carotene
46. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress
47. HIV-induced cysteine deficiency and T-cell dysfunction - A rationale for treatment with N-acetylcysteine
48. Functions of glutathione and glutathione disulfide in immunology and immunopathology
49. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase?
50. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients
51. Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration
52. Resistance of chimpanzee T cells to human immunodeficiency virus type I tat-enhanced oxidative stress and apoptosis
53. Redox and activation status of monocytes from human immunodeficiency virus-infected patients: Relationship with viral load
54. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
55. A capase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
56. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy
57. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
58. Viral dynamics in HIV-1 infection
59. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells
60. B cell development is perturbed in bone marrow from c-fos/v-jun doubly transgenic mice
61. Distinct effects of glutathione disulphide on the transcription factors NFκB and AP-1
62. + T cells by a Fas-independent mechanism
63. Redox signals and NF-kappaB activation in T cells
64. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist
65. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction
66. Mitochondria and apoptosis
67. Modulation of T cell proliferative response by accessory cell interactions
68. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
69. BCL-2 family members and the mitochondria in apoptosis
70. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
71. p53 And Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat
72. Role of free radicals and catalytic metal ions in human disease: An overview
73. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation
74. Redox regulation of apoptotic cell death in the immune system
75. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
76. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells
77. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin
78. Behavior of transaldolase (EC 2.2.1.2.) and transketolase (EC 2.2.1.1.) in normal neoplastic, differentiating, and regenerating liver
79. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death
80. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
81. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxy-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor
82. Glutathione deficiency is associated with impaired survival in HIV disease
83. Reactive oxygen species regulate activation-induced T cell apoptosis
84. Apoptosis: A mechanism of cell killing by influenza A and B viruses
85. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
86. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
87. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1)
88. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism
89. Thioredoxin and thioredoxin reductase
90. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
91. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines
92. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-1 associated neurological disease
93. The HIV-1 viral protein r induces apoptosis via a direct effect on the mitochondrial permeability transition pore
94. Control of RNA initiation and elongation at the HIV-1 promoter
95. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine
96. AIDS wasting syndrome as an enterometabolic disorder: The gut hypothesis
97. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
98. Regulation of Fas ligand expression during activation-induced cell death in T lymphocytes
99. + cells
100. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy
101. The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis
102. Regulators of cell death
103. The nef protein of the human immunodeficiency virus type 1 (HIV-1) inhibits a large-conductance potassium channel in human glial cells
104. Antioxidant therapy and HIV infection: 1998
105. Cerebral glucose transporter expression in HIV infection
106. Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes
107. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation
108. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress
109. Sensitization of the HIV-1-LTR upon long term low dose oxidative stress
110. Elevated levels of circulating cachectins/tumor necrosis factor in patients with acquired immunodeficiency syndrome
111. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
112. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC, PTK, bcl-2, and Fas
113. Is NF-κB the sensor of oxidative stress?
114. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates and apoptotic protease cascade
115. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
116. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: A randomized, controlled pilot study
117. Glutathione and cysteine in HIV-infected hemophiliacs
118. Hydrogen peroxide as a potent activator of T lymphocyte functions
119. IL-2 gene expression and NF-kappaB activation through CD28 requires reactive oxygen production by 5-lipoxygenase
120. Perturbations of glucose metabolism associated with HIV infection in human intestinal epithelial cells: A multinuclear magnetic resonance spectroscopy study
121. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae
122. N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells
123. The role of oxidative imbalance in progression to AIDS: Effect of the thiol supplier N-acetylcysteine
124. U937 cells overexpressing bcl-xl are resistant to human immunodeficiency virus-1-induced apoptosis and human immunodeficiency virus-1 replication
125. Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: Loss of ADF high-producer ceils in lymphoid tissues of AIDS patients
126. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I tax
127. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62
128. The pentose phosphate pathway and other pathways of hexose metabolism
129. 31P-NMR experimental data from human erythrocytes
130. Glutathione-ascorbic acid antioxidant system in animals
131. Glutathione
132. Prognosis of HIV infection predicted by the quantity of virus in plasma
133. Programmed death of T cells in HIV infection
134. Differential expression of apoptosis related Fas antigen on lymphocyte subpopulations in human peripheral blood
135. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: Evidence for cell death by apoptosis
136. Energy expenditure and protein metabolism in human immunodeficiency virus infection and cancer cachexia
137. Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells
138. Elevation of plasma thioredoxin levels in HIV-infected individuals
139. Redox regulation of cellular activation
140. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1
141. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1
142. Application of biochemical systems theory to metabolism in human red blood cells. Signal Propagation and accuracy of representation
143. ASK1 is essential for JNK/SAPK activation by TRAF2
144. Mitochondrial phospholipid hydroperoxide glutathione peroxidase suppresses apoptosis mediated by a mitochondrial death pathway
145. + T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1
146. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism
147. Regulation of NF-kappa B and disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation
148. Requirement of cysteine-rich repeats of the Fas receptor for binding of the Fas ligand
149. Inhibition of murine AIDS by reduced glutathione
150. Temporally distinct patterns of p53-dependent and p53-independent apoptosis apoptosis during mouse lens development
151. The immunopathogenesis of human immunodeficiency virus infection
152. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
153. Multiple redox regulation in NF-kappaB transcription factor activation
154. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology
155. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency
156. Vpr-induced cell cycle arrest is conserved among primate lentiviruses
157. Vitamin C exhibits pro-oxidant properties
158. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and bcl-2 proteins
159. Viral inhibition of inflammation; Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
160. Lipid peroxidation in human immunodeficiency virus infection
161. Increased uptake and accumulation of vitamin C in human immunodeficiency virus 1-infected hematopoietic cell lines
162. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses
163. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia
164. HIV-1 tat: A polypeptide for all seasons
165. Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection
166. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1
167. Modulating factors of radical intensity and cytotoxic activity of ascorbate
168. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression
169. Caspases: Intracellular signaling by proteolysis
170. Is apoptosis mediated by reactive oxygen species?
171. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells
172. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
173. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B
174. Oxidative stress during viral infection: A review
175. Antioxidant and redox regulation of gene transcription
176. Fas mediated apoptosis of human Jurkat T-cells: Intracellular events and potentiation by redox-active alphalipoic acid
177. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptosis, and changes Sp1 DNA binding in HeLa cells
178. Energy balance in asymptomatic HIV infection
179. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux
180. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr
181. Increased production of malondialdehyde in patients with HIV infection
182. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression
183. Glutathione and HIV infection: Reduced reduced, or increased oxidized?
184. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals
185. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus
186. Glutathione deficiency and human immunodeficiency virus infection
187. Redox signaling: Nitrosylation and related target interactions of nitric oxide
188. Apoptosis mediated by HIV protease is preceeded by cleavage of bcl-2
189. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor ceils in vivo
190. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens
191. Changes in purine nucleotide content in the lymphocyte subpopulations of patients infected with HIV
192. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; Possible involvement of dithiol-reduction in the IL-2 receptor induction
193. The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells
194. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
195. Importance of glucose-6-phosphate dehydrogenase activity for cell growth
196. Importance of glucose-6-phosphate dehydrogenase activity in cell death
197. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells
198. Ascorbic acid in aromatic hyroxylation. I. A model system for aromatic hydroxylation
199. Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress
200. Glutathione homeostasis is disturbed in CD4-positive lymphocytes of HIV-seropositive individuals
201. Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: A mechanism for Th2 resistance from Fas-mediated apoptosis
202. Mammalian facilitative hexose transporters mediate the transport of dehyrdoascorbic acid
203. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: Toxicological and pathological implications
204. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
205. Viral dynamics in human immunodeficiency virus type 1 infection
206. Sen0sitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120
207. HIV-1 tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state
208. The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins
209. Association between and oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
210. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS
211. Catalysis of pentose phosphate pathway reactions by cytoplasmic fractions from muscle, uterus and liver of the rat, and the presence of a reduced nicotinamide-adenine dinucleotide phosphatetriose phosphate oxidoreductase in rat muscle
212. Evasion of cytotoxic T lymphocyte (CTL) response by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells
213. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
214. The human T-cell leukemia virus type I tax protein induces apoptosis which is blocked by the bcl-2 protein
215. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked
216. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells
217. + T lymphocytes
218. + T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway
219. +-dependent K+ channel involved in the control of the resting potential in CEM lymphocytes